IRIS UniCatt

Scatena, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.444
EU - Europa 2.859
AS - Asia 2.399
SA - Sud America 457
Continente sconosciuto - Info sul continente non disponibili 75
AF - Africa 61
OC - Oceania 7
Totale 9.302
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.335
SG - Singapore 982
CN - Cina 699
DE - Germania 616
RU - Federazione Russa 537
SE - Svezia 370
BR - Brasile 357
UA - Ucraina 321
FR - Francia 190
VN - Vietnam 186
IT - Italia 181
PL - Polonia 154
GB - Regno Unito 121
IE - Irlanda 118
TR - Turchia 105
FI - Finlandia 97
IN - India 92
ID - Indonesia 79
CA - Canada 63
JP - Giappone 56
BD - Bangladesh 38
HK - Hong Kong 34
AR - Argentina 29
ES - Italia 28
IQ - Iraq 25
BE - Belgio 23
NL - Olanda 23
MX - Messico 21
KR - Corea 19
VE - Venezuela 17
ZA - Sudafrica 16
MA - Marocco 14
CO - Colombia 13
EC - Ecuador 11
PK - Pakistan 11
RO - Romania 10
AE - Emirati Arabi Uniti 8
AT - Austria 8
CH - Svizzera 8
CL - Cile 8
CZ - Repubblica Ceca 8
SA - Arabia Saudita 8
IL - Israele 7
IR - Iran 7
UZ - Uzbekistan 7
KE - Kenya 6
MY - Malesia 6
PE - Perù 6
PT - Portogallo 6
PY - Paraguay 6
UY - Uruguay 6
AU - Australia 5
BY - Bielorussia 5
EG - Egitto 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AL - Albania 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
HN - Honduras 4
JM - Giamaica 4
LT - Lituania 4
DK - Danimarca 3
GR - Grecia 3
JO - Giordania 3
KZ - Kazakistan 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
PH - Filippine 3
AO - Angola 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CR - Costa Rica 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GN - Guinea 1
KG - Kirghizistan 1
KH - Cambogia 1
MD - Moldavia 1
Totale 9.218
Salva come PNG Salva come JPEG
Città #
Singapore 501
Ashburn 417
Chandler 406
San Jose 289
Jacksonville 157
Warsaw 150
Beijing 125
San Mateo 116
Dublin 113
Nanjing 106
New York 92
Wilmington 84
The Dalles 72
Los Angeles 69
Woodbridge 69
Ann Arbor 68
Houston 66
Jakarta 65
Izmir 62
Lauterbourg 60
Fairfield 58
Hefei 58
Dearborn 57
Ho Chi Minh City 52
Boston 49
Hanoi 46
Lawrence 45
Seattle 44
Tokyo 44
Redmond 43
Chicago 39
Cattolica 37
São Paulo 34
Moscow 33
Frankfurt am Main 32
Hong Kong 31
Helsinki 28
Bremen 27
Mountain View 25
Shanghai 25
Cambridge 23
Kunming 23
Redwood City 23
Montreal 22
Boardman 21
Munich 21
Nürnberg 20
Zhengzhou 20
Kent 19
Detroit 18
Milan 18
Nanchang 18
Princeton 18
Dallas 17
Hangzhou 17
Shenyang 17
London 16
Rome 16
Santa Clara 16
Brussels 15
Hebei 15
Guangzhou 14
Buffalo 13
Lancaster 13
Philadelphia 13
Toronto 13
University Park 13
Atlanta 12
Brooklyn 12
Marseille 12
Pune 12
Jiaxing 11
Seoul 11
Belo Horizonte 10
Changsha 10
Johannesburg 10
Orem 10
Baghdad 9
Dhaka 9
Paris 9
Phoenix 9
Tianjin 9
Turku 9
Edinburgh 8
Cardiff 7
Da Nang 7
Düsseldorf 7
Haiphong 7
Lanzhou 7
Memphis 7
Simi Valley 7
Stockholm 7
Tashkent 7
Chengdu 6
Chennai 6
Curitiba 6
Indiana 6
Istanbul 6
Madrid 6
Manchester 6
Totale 4.643
Salva come PNG Salva come JPEG
Nome #
FUNCTIONAL ALTERATIONS IN ADULT AND FETAL HEMOGLOBIN SASSARI ASP-ALPHA-126(H9) -] HIS - THE ROLE OF ALPHA(1)ALPHA(2) CONTACT 608
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing 413
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects 207
CA 19-9: Biochemical and Clinical Aspects 200
Advances in Cancer Biomarkers - From biochemistry to clinic for a critical revision 198
Advances in Cancer Stem Cell Biology 194
A proteomic approach to characterizing ciglitazone-induced cancer cell differentiation in Hep-G2 cell line 190
Neuron Specific Enolase as a biomarker: biochemical and clinical aspects 190
MITOCHONDRIAL DAMAGE AND METABOLIC COMPENSATORY MECHANISMS INDUCED BY HYPEROXIA IN U-937 CELL LINE. 189
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 3. Discovery of Novel Lead Compounds Through Structure-Based Drug Design and Docking Studies 187
Mitochondrial proteomic approaches for new potential diagnostic and prognostic biomarkers in cancer 177
Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology. 176
Derangement of erythrocytic AE1 in beta-thalassemia by caspase 3: pathogenic mechanisms and implications in red blood cell senescence 173
Prognostic value of the reactive oxygen species in severe sepsis and septic shock patients: a-pilot study 172
The epithelial–mesenchymal transition in cancer: a potential critical topic for translational proteomic research 168
Advances in Mitochondrial Medicine 165
A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists. 163
An update on pharmacological approaches to neurodegenerative diseases. 161
A Critical Approach to Clinical Biochemistry of Chromogranin A 161
Immunological role of IgG subclasses 160
The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects 158
Circulating tumour cells and cancer stem cells: A role for proteomics in defining the interrelationships between function,phenotype and differentiation with potential clinical applications. 156
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 2. Effect of Pyrrole C2 and/or C4 Substitutions on Biological Activity 153
Bezafibrate Induces a Mitochondrial Derangement in Human Cell Lines. Intriguing Effects for a Peroxisome Proliferator. 152
CA 19-9: Biochemical and Clinical Aspects 150
Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy 147
The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. 145
Oxygen transport by Fetal Bovine Hemoglobin 139
The proteomics of cancer stem cells. Potential clinical applications for innovative research in oncology 138
Cancer stem cells: the development of new cancer therapeutics 134
Cancer Stem Cells: An Innovative Therapeutic Approach 133
Modulation of cancer cell line differentiation: A neglected proteomic analysis with potential implications in pathophysiology, diagnosis, prognosis, and therapy of cancer. 132
Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential. 132
CA 19-9: Biochemical and Clinical Aspects 129
Immunological role of IgG subclasses 129
Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications 127
Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks. 126
The role of CA 125 as tumor marker: biochemical and clinical aspects 124
A critical approach to clinical biochemistry of Chromogranin A 124
Cancer Stem Cells: Proteomic Approaches for New Potential Diagnostic and Prognostic Biomarkers 123
Cancer Biomarkers: A Status Quo 122
Advances in Heat Shock Proteomics: Towards a Better Understanding of the Physiology and Pathophysiology of Molecular Chaperones. 121
EFFECTS OF GEMFIBROZIL ON THE OXYGEN-TRANSPORT PROPERTIES OF ERYTHROCYTES 117
Toward the Standardization of Mitochondrial Proteomics: The Italian Mitochondrial Human Proteome Project Initiative 112
Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation growth inhibition and terminal cell differentiation 111
Resveratrol treatment induces redox stress in red blood cells: a possible role of caspase 3 in metabolism and anion transport 111
Glycolytic enzyme inhibitors in cancer treatment. 110
Cancer Stem Cells: A Revisitation of the “Anaplasia” Concept. In Advances in Cancer Stem Cell Biology 107
SEPARATION OF REDUCED AND OXIDIZED GLUTATHIONE BY MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY 105
Exploring the connection unit in the HDAC inhibitor pharmacophore model: novel uracil-based hydroxamates. 102
THE MULTIPLE FUNCTIONS OF HEMOGLOBIN 101
Mitochondrial respiration and differentiation 101
Glycated human hemoglobin (HbA1c): functional characteristics and molecular modeling studies 100
Aroyl-Pyrrolyl Hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetilase inhibition 97
PHYSIOLOGICAL RELEVANCE OF THE OVERALL DELTA-H OF OXYGEN BINDING TO FETAL HUMAN HEMOGLOBIN 95
Cellular respiration and dedifferentiation 93
Mitochondria and drugs 93
The plasma membrane of erythrocytes plays a fundamental role in the transport of oxygen, carbon dioxide and nitric oxide and in the maintenance of the reduced state of the heme iron. 92
Mitochondria and cancer: a growing role in apoptosis, cancer cell metabolism and dedifferentiation 88
Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key? 84
Cytotoxicity of a new endodontic filling material 84
Aroyl-pyrrolyl hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetylase inhibition. 82
Nitroflurbiprofen (NicOx). 71
Totale 9.302
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022519 0 69 9 59 32 24 14 91 17 26 73 105
2022/20231.663 154 191 94 169 94 137 29 118 583 26 52 16
2023/2024458 25 142 5 12 19 75 16 22 5 23 63 51
2024/20251.120 34 25 85 35 98 43 33 74 156 138 189 210
2025/20262.750 421 103 171 279 406 189 531 151 202 173 67 57
2026/2027119 100 19 0 0 0 0 0 0 0 0 0 0
Totale 9.302